Business
Daily Coverage on Healthcare Stocks: Spectral Medical, ProMIS Neurosciences, GeneNews, and Novadaq Technologies
LONDON, UK / ACCESSWIRE / June 19, 2017 / Pro-Trader Daily has lined up these stocks for our...
About this update from Spectral Medical Inc
[{"type":"text","content":"Daily Coverage on Healthcare Stocks: Spectral Medical, ProMIS Neurosciences, GeneNews, and Novadaq TechnologiesLONDON, UK / ACCESSWIRE / June 19, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Medical Diagnostics & Research industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Spectral Medical, ProMIS Neurosciences, GeneNews, and Novadaq Technologies. Register for these free reports at:\n \nhttp://protraderdaily.com/register/\n \nOn Friday, June 16, 2017, the Toronto Exchange Composite Index was up 0.21%, finishing the day at 15,192.54.\n \nAdditionally, the Healthcare index was slightly up by 0.53%, ending the session at 64.88.\n \nPro-Trader Daily's complimentary research reports on the following stocks are now available: Spectral Medical Inc. (TSX: EDT), ProMIS Neurosciences Inc. (TSX: PMN), GeneNews Ltd (TSX: GEN), and Novadaq Technologies Inc. (TSX: NDQ). Sign up now for your free membership and research reports at:\nhttp://protraderdaily.com/register/\n \nSpectral Medical Inc.\n \nToronto, Canada headquartered Spectral Medical Inc.'s stock fell 6.25%, to finish Friday's session at $0.45 with a total volume of 69,921 shares traded. Spectral Medical's shares have gained 26.76% in the past three months. Shares of the Company, which focuses on the development and commercialization of theranostic treatment for septic shock in North America, are trading above its 200-day moving average. Spectral Medical's 50-day moving average of $0.50 is above its 200-day moving average of $0.38. See our research report on EDT.TO at:\nhttp://protraderdaily.com/optin/?symbol=EDT \nProMIS Neurosciences Inc.\n \nOn Friday, shares in Toronto, Canada headquartered ProMIS Neurosciences Inc. recorded a trading volume of 436,330 shares, which was higher than their three months average volume of 425,803 shares. The stock ended the day 5.00% lower at $0.29. ProMIS Neurosciences' stock has surged 64.71% in the last three months and 154.55% in the previous one year. Shares of the Company, which discovers and develops precision medicine therapeutics for treatment of neurodegenerative diseases, primarily Alzheimer's disease and amyotrophic lateral sclerosis, are tr...